About Invivyd

Invivyd is a clinical-stage a biotechnology company developing best-in-class antibodies that can broadly neutralize SARS-CoV-2, SARS-CoV-1 and additional pre-emergent coronaviruses.

Leadership at Invivyd

The team at the top of the org chart.

Robert Allen

Chief Scientific Officer

14 reports

Philip Levesque

Vice President, Technical Operations

5 reports

Julie Green

Chief Human Resources Officer and Interim Head of Communications

4 reports

Kate Fisher

Senior Vice President, Corporate Counsel

3 reports

Ilker Yalcin

SVP And Head Of Biostatistics, Statistical Programming And Data Management

2 reports

RG

Reginald Gay, MD

Vice President, Global Drug Safety & Pharmacovigilance

1 report

PH

Pamela Hawn

Senior Director Medical Affairs, Scientific Communications And Strategy

1 report

Keith White

Head Of Drug Substance Manufacturing

1 report

Nick Vannelli

Sr. Consultant Engineer At Invivyd Inc.

KW

Keisha Wilson-Anderson

Consultant

JS

Jessica Svendsen

Associate Director, Clinical Quality Assurance

Colin Powers

Director Of Virology

4 reports

MW

Mark Wingertzahn

Head Of Clinical Development, Drug Safety & Medical Affairs

3 reports

Feng Gao

Senior Director, Antibody Discovery

2 reports

RG

Rachael Gerlach

Senior Vice President, Head of Regulatory Affairs

Brandyn West, Ph.D.

Director - Discovery & Nonclinical Development

Shannon Holmes

Vp, CMC Regulatory And Quality

2 reports

Paul Grous

Head Of IT

1 report

MM

Mark Marmur

Senior Director, External Communications

1 report

Board

TB

Tamsin Berry

Director

CL

Christine Lindenboom

Director

Marc Elia

Chairman of the Board

TM

Terry McGuire

Director

TH

Tom Heyman

Director

Michael Wyzga

Director

Open Jobs at Invivyd (17)

Sort